InsiderDB

SEC EDGAR · Company announcement

CYTK: Other company developments

Filed 8-K for an event or period dated 2026-08-28. Other company developments.

Follow CYTK
Became public
Aug 28, 2026, 9:21 AM EDT
Event / period date
Aug 28, 2026
Collected
Nov 9, 2026, 6:17 AM EST

Why this is connected

This filing identifies CYTOKINETICS INC as the issuer of the security. The company's SEC identifier connects it to CYTK.

Press Release dated August 28, 2026 ↗

Source evidence

Read the source excerpt or record
Item 8.01 Other Events. On August 28, 2026, Cytokinetics, Incorporated issued a press release announcing its presentation of the full results of ACACIA-HCM at the European Society of Cardiology (ESC) Congress 2026 and published in the New England Journal of Medicine. The full text of the press release issued in connection with this announcement is incorporated herein as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release dated August 28, 2026 104 The cover page of this report has been formatted in Inline XBRL SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYTOKINETICS, INCORPORATED Date: August 28, 2026 By: /s/ John O. Faurescu John O. Faurescu SVP, Deputy General Counsel & Secretary

Price change after we could observe it

+4.18% CYTK

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in CYTK

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.